Investigation of Interleukin-38 in patients with primary Sjögren’s Syndrome
Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · 2022
DOI: 10.20492/aeahtd.1035777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, 2022. Verfasst von Selcan GÜLTUNA und 2 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Gefördert von: yok.
Abstract (Originalsprache)
Aim: Interleukin-38 has been involved as an inflammatory mediator in rheumatic diseases. However, little is known about the role of IL-38 in the development of primary Sjögren’s syndrome. The present study aimed to evaluate the role of IL-38 in primary Sjögren’s syndrome and its clinical relevance. Material and Method:Between 2019 and 2020, 40 patients with primary Sjögren’s syndrome and 39 healthy participants were included in the study. The serum IL-38 level was measured by ELISA in all participants. The serum levels of IL-38 were compared with clinical and laboratory features. Results:The serum IL-38 levels between the patients with primary Sjögren’s syndrome and the controls were similar (58.0 pg/ml, min-max: 0-641.0 vs. 55.0 ng/ml, min-max: 0-338.0; p=0.511). No significant correlations were found between serum IL-38 level and SSDAI (r=-0.104, p=0.523). IL-38 level was mildly negatively correlated with RF (r=-0.364, p=0.021) and positively correlated with CRP (r=0.321, p= 0.044). Conclusion:The correlation of IL-38 with CRP and RF should be considered because it might be important clues for contribution to the disease process. IL-38 might be relevant to the heterogeneous nature of PSS and the future role of IL-38 might be a biomarker for specific clinical manifestations of pSS.
Förderung
- yok
Zitieren
APA
GÜLTUNA, S., CAN, S., & AYDİN, F. N. (2022). Investigation of Interleukin-38 in patients with primary Sjögren’s Syndrome. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi. https://doi.org/10.20492/aeahtd.1035777
Vancouver
GÜLTUNA S, CAN S, AYDİN FN. Investigation of Interleukin-38 in patients with primary Sjögren’s Syndrome. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi. 2022. doi:10.20492/aeahtd.1035777
BibTeX
@article{GLTUNA2022,
author = {GÜLTUNA, Selcan and CAN, Sevinc and AYDİN, Fevzi Nuri},
title = {Investigation of Interleukin-38 in patients with primary Sjögren’s Syndrome},
journal = {Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi},
year = {2022},
doi = {10.20492/aeahtd.1035777}
}
EUVIMED